Healthcare -
Biotechnology - NASDAQ - US
$ 2.4
-2.44 %
$ 128 M
Market Cap
-2.53
P/E
TCRX - OPERATING EXPENSES
Operating Expenses TCRX - TScan Therapeutics, Inc.
115 M
LAST VALUE
39.57%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR